EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endocrine Implications of Thyroid Incidentalomas Detected During Lymphoma Staging With 18F‐Fluorodeoxyglucose Positron Emission Tomography

Marcos Tadashi Kakitani Toyoshima iD, Roberta Morgado Ferreira Zuppani, Isabelle Pinheiro Amaro, Camila Regina Pereira Batista de Macedo, Ricardo Miguel Costa de Freitas, Rodrigo Dolphini Velasques, Juliana Pereira, Rafael Loch Batista, Debora Lúcia Seguro Danilovic, Delmar Muniz Lourenço, Ana O Hoff

Clinical Endocrinology · 2025

DOI: 10.1111/cen.15295 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology, 2025. Verfasst von Marcos Tadashi Kakitani Toyoshima und 10 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine Oncology Service, Instituto do Câncer do Estado de São Paulo Octávio Frias de Oliveira, Hospital das Clínicas da Faculdade de Medicina da U…. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Lymphoma, Thyroid Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study investigated the prevalence, characteristics, and endocrine implications of thyroid incidentalomas detected during lymphoma staging using FDG‐PET/CT.

Design

Retrospective cohort study. Patients A total of 795 adult patients with lymphoma who underwent FDG‐PET/CT for staging at a tertiary oncology centre were included.

Measurements

Thyroid uptake was classified as focal, diffuse, or absent. Additional data included demographic features, lymphoma subtype, thyroid function, autoantibodies, ultrasound (US), fine‐needle aspiration cytology (FNAC), and histopathology when available.

Results

Thyroid abnormalities were detected in 139 patients (17.5%). Focal FDG uptake was observed in 33 patients (4.2%) and was associated with a malignancy rate of 18.2% (28.6% among those who underwent FNAC). Diffuse uptake was observed in 20 patients (2.5%) and was significantly associated with positive thyroid autoantibodies (58.3%, p < 0.01). Older age and female gender were independent predictors of thyroid uptake. ROC analysis identified optimal age thresholds of 68.6 years for females and 59.8 years for males (AUC = 0.72). SUVmax, Hounsfield units, and ACR TI‐RADS classification were not significantly associated with malignancy. All malignant cases occurred in nodules classified as TI‐RADS 4 or 5. Volume on CT was inversely associated with malignancy ( ρ = –0.50, p = 0.046). No significant impact on overall survival was observed.

Conclusions

Thyroid incidentalomas are frequent during lymphoma staging by FDG‐PET/CT and should be appropriately evaluated. Focal uptake carries a relevant malignancy risk, even in nodules with low SUVmax. Diffuse uptake often reflects autoimmune thyroiditis. A multimodal diagnostic approach is essential to guide management and avoid unnecessary delays in cancer care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18LymphomaThyroid NeoplasmsHumansFemaleMaleMiddle AgedRetrospective StudiesAgedPositron Emission Tomography Computed TomographyAdultNeoplasm StagingAged, 80 and overIncidental FindingsThyroid Gland

Stichwörter der Autor:innen

FDG‐PETThyroid incidentalomaslymphomathyroid autoimmunitythyroid malignancy

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Endocrine Oncology Service, Instituto do Câncer do Estado de São Paulo Octávio Frias de Oliveira, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Department of Radiology and Oncology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Department of Internal Medicine, Division of Endocrinology and Metabolism, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Laboratorio de Endocrinologia Celular e Molecular (LIM 25), Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Brazil.

ORCID-Profile: Marcos Tadashi Kakitani Toyoshima

Förderung

  • This study received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Zitieren

APA

Toyoshima, M. T. K., Zuppani, R. M. F., Amaro, I. P., de Macedo, C. R. P. B., de Freitas, R. M. C., Velasques, R. D., Pereira, J., Batista, R. L., Danilovic, D. L. S., Lourenço, D. M., & Hoff, A. O. (2025). Endocrine Implications of Thyroid Incidentalomas Detected During Lymphoma Staging With 18F‐Fluorodeoxyglucose Positron Emission Tomography. Clinical Endocrinology. https://doi.org/10.1111/cen.15295

Vancouver

Toyoshima MTK, Zuppani RMF, Amaro IP, de Macedo CRPB, de Freitas RMC, Velasques RD, et al. Endocrine Implications of Thyroid Incidentalomas Detected During Lymphoma Staging With 18F‐Fluorodeoxyglucose Positron Emission Tomography. Clinical Endocrinology. 2025. doi:10.1111/cen.15295

BibTeX
@article{Toyoshima2025,
  author = {Toyoshima, Marcos Tadashi Kakitani and Zuppani, Roberta Morgado Ferreira and Amaro, Isabelle Pinheiro and de Macedo, Camila Regina Pereira Batista and de Freitas, Ricardo Miguel Costa and Velasques, Rodrigo Dolphini and Pereira, Juliana and Batista, Rafael Loch and Danilovic, Debora Lúcia Seguro and Lourenço, Delmar Muniz and Hoff, Ana O},
  title = {Endocrine Implications of Thyroid Incidentalomas Detected During Lymphoma Staging With 18F‐Fluorodeoxyglucose Positron Emission Tomography},
  journal = {Clinical Endocrinology},
  year = {2025},
  doi = {10.1111/cen.15295}
}
Kostenlos starten →